Outcomes of a nine-month regimen for rifampicin-resistant tuberculosis up to 24 months after treatment completion in nine African countries
Sign Up to like & getrecommendations! Published in 2020 at "EClinicalMedicine"
DOI: 10.1016/j.eclinm.2020.100268
Abstract: Background Treatment outcomes of the shorter regimen for rifampicin-resistant tuberculosis are not completely established. We report on these outcomes two years after treatment completion among patients enrolled in an observational cohort study in nine African… read more here.
Keywords: regimen rifampicin; treatment; rifampicin resistant; treatment completion ... See more keywords
Efficacy of an ethyl alcohol gel in symptomatic disc herniation.
Sign Up to like & getrecommendations! Published in 2018 at "European journal of radiology"
DOI: 10.1016/j.ejrad.2018.10.029
Abstract: PURPOSE To evaluate the clinical outcome of DiscoGel® chemonucleolysis for symptomatic disc herniation in patients who fail conservative treatment. MATERIAL AND METHODS Consecutive patients with symptomatic disc herniation confirmed on MRI who failed conservative management… read more here.
Keywords: months treatment; treatment; symptomatic disc; disc herniation ... See more keywords
Eighteen Months of Treatment With Subcutaneous Abaloparatide Followed by 6 Months of Treatment With Alendronate in Postmenopausal Women With Osteoporosis: Results of the ACTIVExtend Trial
Sign Up to like & getrecommendations! Published in 2017 at "Mayo Clinic Proceedings"
DOI: 10.1016/j.mayocp.2016.10.009
Abstract: Objective To assess the efficacy and safety of 18 months of subcutaneous abaloparatide (ABL‐SC) or placebo (PBO) followed by 6 months of alendronate (ALN) (preplanned interim analysis). Patients and Methods ACTIVExtend, an extension of ACTIVE,… read more here.
Keywords: followed months; risk; treatment; aln ... See more keywords
Serological Response Predicts Normalization of Cerebrospinal Fluid Abnormalities at Six Months after Treatment in HIV-Negative Neurosyphilis Patients
Sign Up to like & getrecommendations! Published in 2017 at "Scientific Reports"
DOI: 10.1038/s41598-017-10387-x
Abstract: This study aimed to determine whether a serological response could predict the normalization of cerebrospinal fluid (CSF) abnormalities at 6 months after treatment in human immunodeficiency virus (HIV)-negative neurosyphilis patients. A total of 123 neurosyphilis… read more here.
Keywords: treatment; neurosyphilis patients; csf; serological response ... See more keywords
P14.92 Study of Glutaminergic and Glutamatergic Metabolism in 1H-MRS Monovoxel in the Most Aggressive Part of 62 Glioblastoma Before and After 18 months Treatment
Sign Up to like & getrecommendations! Published in 2019 at "Neuro-Oncology"
DOI: 10.1093/neuonc/noz126.327
Abstract: To study the relationships between glutaminergic metabolism (Glx/tCr), tumor proliferation (tCho/tCr) and other metabolic activities in patients with glioblastoma (GBM). Patients: 62 patients with glioblastoma, all having a STUPP Protocol (radiotherapy and concomitant chemotherapy), were… read more here.
Keywords: glx tcr; study; months treatment; glx ... See more keywords
Factors associated with swallowing dysfunction in patients with head and neck cancer.
Sign Up to like & getrecommendations! Published in 2022 at "Oral diseases"
DOI: 10.1111/odi.14192
Abstract: BACKGROUND The aim of this prospective cohort study was to investigate swallowing function in relation to personal and clinical factors among patients with head and neck cancer (HNC) from diagnosis up to 2 years after… read more here.
Keywords: patients head; neck cancer; head neck; factors associated ... See more keywords
THU0211 Six months after treatment discontinuation tnf is still in complex with adalimumab
Sign Up to like & getrecommendations! Published in 2018 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2018-eular.5526
Abstract: Background Many patients with rheumatoid arthritis (RA) are successfully treated with tumour necrosis factor inhibitors (TNFi). We recently developed a novel assay that can quantify TNF in the presence of large amounts of TNFi, i.e.… read more here.
Keywords: tnf; adalimumab; tnf levels; discontinuation ... See more keywords
Combination of mesenchymal stem cells (MSCs) and platelet-rich plasma (PRP) in the treatment of knee osteoarthritis: a meta-analysis of randomised controlled trials
Sign Up to like & getrecommendations! Published in 2022 at "BMJ Open"
DOI: 10.1136/bmjopen-2022-061008
Abstract: Objectives The purpose of this meta-analysis was to investigate the efficacy and safety of mesenchymal stem cells (MSCs) combined with platelet-rich plasma (PRP) in the treatment of knee osteoarthritis (KOA). Design Systematic review and meta-analysis.… read more here.
Keywords: meta analysis; mscs prp; prp; months treatment ... See more keywords
Associations with visual acuity outcomes after 12 months of treatment in 9401 eyes with neovascular AMD
Sign Up to like & getrecommendations! Published in 2022 at "BMJ Open Ophthalmology"
DOI: 10.1136/bmjophth-2022-001038
Abstract: Objective To record visual acuity outcomes after 12 months of treatment for neovascular age-related macular degeneration (NvAMD), investigate variation between sites and explore associations with baseline characteristics and care processes. Methods and analysis Anonymised demographic… read more here.
Keywords: acuity; months treatment; visual acuity; acuity outcomes ... See more keywords
High Prevalence and Conservative Management of Acute Cholecystitis during Lenvatinib for Advanced Thyroid Cancer
Sign Up to like & getrecommendations! Published in 2020 at "European Thyroid Journal"
DOI: 10.1159/000510369
Abstract: Introduction: Lenvatinib (LEN) is a multitarget tyrosine kinase inhibitor currently used for advanced, radioiodine refractory differentiated thyroid cancer (RAI-R DTC). Among adverse events (AEs), nausea, vomiting, and decreased appetite have been frequently described. We aimed… read more here.
Keywords: first months; treatment; prevalence; thyroid cancer ... See more keywords
Effects on Glyco-Metabolic Control after 12 Months of Treatment with a Supplement of Ilex Paraguariensis, White Mulberry and Chromium Picolinate in Non-Diabetic Patients with Dysglycemia
Sign Up to like & getrecommendations! Published in 2023 at "Journal of Food and Nutrition Research"
DOI: 10.12691/jfnr-11-4-6
Abstract: The primary endpoint of the current study was to evaluate whether the effects previously demonstrated in the 3-month study could be maintained for 12 months. Patients were randomized to take Glicoset® in addition to a… read more here.
Keywords: group treated; treated nutraceutical; diet alone; group ... See more keywords